tiprankstipranks
Bright Minds Biosciences (TSE:DRUG)
CNQX:DRUG
Holding TSE:DRUG?
Track your performance easily

Bright Minds Biosciences (DRUG) Ownership - Who Owns Bright Minds Biosciences?

56 Followers

Bright Minds Biosciences (DRUG) Ownership Overview

28.60%2.63%0.04%68.73%
28.60% Insiders
2.63% Other Institutional Investors
0.04% ETFs
68.73% Public Companies and
Individual Investors
The ownership structure of Bright Minds Biosciences (TSE:DRUG) stock is a mix of institutional, retail, and individual investors. , 28.60% is owned by Insiders, and 68.73% is owned by Public Companies and Individual Investors.
The ownership structure of Bright Minds Biosciences (TSE:DRUG) stock is a mix of institutional, retail, and individual investors. Approximately 2.67% of the company’s stock is owned by Institutional Investors, 28.60% is owned by Insiders, and 68.73% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 11, 2024
Jan Torleif Pedersen
Chief Scientific Officer
xxxxxxxxxxxxx
C$1411795
Nov 14, 2024
Nils Bottler
Non Executive,director
xxxxxxxxxxxxx
$653408
Nov 12, 2024
Ryan Cheung
Chief Financial Officer
xxxxxxxxxxxxx
C$399010
Nov 11, 2024
Nils Bottler
Non Executive,director
xxxxxxxxxxxxx
$248975

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,059,331Insider15.25%40,283,180
674,900Insider9.71%25,664,422
193,549Insider2.79%7,360,088
35,000Insider0.50%1,330,945
19,750Insider0.28%751,033
5,000Insider0.07%190,135
3,048Institution0.04%115,906

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,048Institution0.04%117,805

FAQ

Who Owns Bright Minds Biosciences (TSE:DRUG)?
According to the latest TipRanks data, approximately 2.63% of the company's stock is held by institutional investors, 28.60% is held by insiders, and 68.73% is held by retail investors.
    What percentage of Bright Minds Biosciences (TSE:DRUG) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.63% of Bright Minds Biosciences (TSE:DRUG) stock is held by institutional investors.
      What percentage of Bright Minds Biosciences (TSE:DRUG) stock is held by retail investors?
      According to the latest TipRanks data, approximately 68.73% of Bright Minds Biosciences (TSE:DRUG) stock is held by retail investors.
        Who owns the most shares of Bright Minds Biosciences (TSE:DRUG)?
        Cormorant Asset Management LP owns the most shares of Bright Minds Biosciences (TSE:DRUG).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis